Latest News and Press Releases

Amsterdam, The Netherlands - 10 October 2017 As of today, EUR 2,700,000 of notes out of the total commitment amounting to EUR 9 million have been converted into shares and EUR 112,500 of...

CryoSave continues its European expansion through a partnership with the company Innovatsiyni Tekhnologiyi, based in Kiev. Amsterdam, The Netherlands - 9 October 2017 Increasing number of...

CEO, Frédéric Amar will convert 1.5 million shares and will subscribe to 1 million new shares to support the business. Zutphen, The Netherlands - 2 October 2017 Esperite NV (Euronext: ESP,...

        Zutphen, The Netherlands - 29 September 2017 Esperite N.V. (Euronext: ESP, the "Company" or "Esperite") announces that the Company expects to publish its Interim Financial Reporting on or...

Zutphen, The Netherlands, 31 August 2017  Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today the Seventh Tranche of EUR 250,000 is issued as a private placement of 25...

Zutphen, The Netherlands, 11 August 2017  As of today, EUR 2,090,000 of notes out of the total commitment amounting to EUR 9 million have been converted into shares and EUR 250,000 of warrants...

Zutphen, The Netherlands, 5 July 2017  Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today a fourth Packed Tranche of EUR 250,000 is issued as a private placement of 25...

  Zutphen, The Netherlands, 15 June 2017  Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today a third Packed Tranche of EUR 250,000 is issued as a private placement of 25...

Zutphen, The Netherlands, 1 June 2017  As of today, 100% of the EUR 1.0 million initial tranche issued on March 8, 2017 has been converted into shares by European Select Growth Opportunities Fund...

Zutphen, The Netherlands, 31 May 2017  As of today, EUR 940,000 out of the EUR 1.0 million tranche issued on March 8, 2017 have been converted into shares by European Select Growth Opportunities...